{"organizations": [], "uuid": "7f92c1d4c78a171e7af577c229ad976ede71b1eb", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180219.html", "section_title": "Archive News &amp; Video for Monday, 19 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-osmotica-pharmaceutical-says-fda-a/brief-osmotica-pharmaceutical-says-fda-approves-osmolex-er-for-treatment-of-parkinsons-disease-idUSASB0C69W", "country": "US", "domain_rank": 408, "title": "BRIEF-Osmotica Pharmaceutical Says FDA Approves OSMOLEX ER For Treatment Of Parkinson’s Disease", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 1.0, "site_type": "news", "published": "2018-02-20T02:03:00.000+02:00", "replies_count": 0, "uuid": "7f92c1d4c78a171e7af577c229ad976ede71b1eb"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-osmotica-pharmaceutical-says-fda-a/brief-osmotica-pharmaceutical-says-fda-approves-osmolex-er-for-treatment-of-parkinsons-disease-idUSASB0C69W", "ord_in_thread": 0, "title": "BRIEF-Osmotica Pharmaceutical Says FDA Approves OSMOLEX ER For Treatment Of Parkinson’s Disease", "locations": [], "entities": {"persons": [{"name": "parkinson", "sentiment": "none"}], "locations": [{"name": "us", "sentiment": "none"}], "organizations": [{"name": "fda", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 19 (Reuters) - Osmotica Pharmaceutical US LLC:\n* FDA APPROVES OSMOTICA PHARMACEUTICAL’S ONCE-DAILY OSMOLEX ER™ (AMANTADINE) EXTENDED-RELEASE TABLETS FOR THE TREATMENT OF PARKINSON’S DISEASE AND DRUG-INDUCED EXTRAPYRAMIDAL REACTIONS IN ADULTS Source text for Eikon:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-20T02:03:00.000+02:00", "crawled": "2018-02-20T14:13:15.000+02:00", "highlightTitle": ""}